Manning, Soleno Therapeutics CCO, sells $229k in SLNO stock
#Soleno Therapeutics #SLNO #insider sale #stock transaction #CCO #regulatory filing #biotech #executive
📌 Key Takeaways
- Soleno Therapeutics CCO Manning sold $229,000 worth of company stock.
- The sale was disclosed in a recent regulatory filing.
- The transaction may reflect personal financial decisions by the executive.
- Investors often monitor insider sales for insights into company outlook.
🏷️ Themes
Insider Trading, Biotechnology
Entity Intersection Graph
No entity connections available yet for this article.